Updated Jul 16, 2026
Shacham Sharon has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Shacham Sharon is an individual referenced in 2026 SEC filings in connection with Acrivon Therapeutics, Inc. Public biographical information about this person is limited beyond their appearance as an insider or affiliate in the SEC documentation. The available filings do not disclose a widely publicized professional background or career history for this person. There is no indication of death as of the most recent filing date (May 20, 2026).
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ACRV | Acrivon Therapeutics, Inc. | A — Grant or award | 9.4K | $0.00 |
Shacham Sharon is an individual referenced in 2026 SEC filings in connection with Acrivon Therapeutics, Inc. Public biographical information about this person is limited beyond their appearance as an insider or affiliate in the SEC documentation. The available filings do not disclose a widely publicized professional background or career history for this person. There is no indi…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shacham Sharon profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.